Other News

The EANcore COVID-19 inatitive has launched a survey on neurological symptoms in COVID-19 patients.

During an extraordinary virtual meeting held on 2 April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how the investigational antiviral medicine remdesivir should be used for treating coronavirus disease (COVID-19) in compassionate use programmes in the European Union.

The European Reference Netowrk for Epilepsy (EpiCARE) will hold a special webinar on Tuesday, April 7 with experts from Spain and Italy on the change to epilepsy care due to the COVID-19 pandemic.

Prof. Claudio Bassetti, President of the EAN and Prof. Mohamed Al-Shehab, President of the PAUNS are pleased to announce that: EAN signed a Memorandum of Understanding with PAUNS – Pan Arab Union of Neurological Societies joining forces to promote optimal… Continue Reading

The World Muslcle Society has recently published its position and advice on the COVID-19 and people with neuromuscular disorders.

Prof. Claudio Bassetti, President of the EAN and Prof. Wim Oyen, President of the EANM are pleased to announce that: EAN signed a Memorandum of Understanding with EANM – European Association of Nuclear Medicine joining forces to promote optimal cooperation… Continue Reading

During this time of uncertainty regarding COVID-19, the 30th Alzheimer Europe Conference #30AEC is still planned to take place in Bucharest from 20-22 October 2020. Our call for abstracts is open, as are registrations, with Early Bird fees available until… Continue Reading

As part of the EU’s Civil Protection Mechanism, on 19 March, the European Commission decided to create a Strategic RescEU Stockpile of medical equipment such as ventilators and protective masks to help EU countries in the context of the COVID-19… Continue Reading

RETHINKING MS in Europe, offering tangible policy changes to improve the lives of people living with MS across Europe, went live during Brain Awareness Week On the occasion of the Brain Awareness Week (16-22 March 2020), the European Brain Council… Continue Reading

WHO Europe launches an on-line consultation on the update of the WHO Comprehensive (Global) Mental Health Action Plan – GMHAP As determined by the World Health Assembly last year, WHO’s Comprehensive Mental Health Action Plan 2013-2020 has been extended to… Continue Reading

In a marathon debate of the European Council on 20-21 February, where the heads of state and government European Member States meet, representatives failed to agree on the EU budget for 2021-2027. This budget includes Horizon Europe, the next funding programme for research and innovation. Long term budget negotiations are known to be difficult, but this time around the departure of the UK, a major budget contributor, intensified the discussions. It is likely that more European summits will be needed to come to conclusion on this topic.

The BioMed Alliance started 2020 well, with a new President, President-Elect and a new Board Member. We look forward to working with them on the many interesting activities that we are planning this year.

The global momentum to deliver a more coordinated response to the threat posed by neurological disorders is increasing.

On 18 February, at a European Parliament lunch debate hosted by Christophe Hansen MEP (Luxembourg), Alzheimer Europe launched a new report presenting the findings of its collaborative analysis of recent prevalence studies and setting out updated prevalence rates for dementia in Europe.